Invitrogen™ Human Flt-3 ELISA Kit

Ref.: BL-RE-093620Manufacturer ref.: EH197RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human Flt-3 quantitates human Flt-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Flt-3.

Accession number
B230315G04 ; CD135 ; antigène CD135 ; kinase 2 du foie fœtal ; kinase-2 du foie fœtal ; récepteur de cytokine FL ; Flk2 ; Flk-2 ; FLT3 ; Flt-3 ; tyrosine kinase 3 associée à la fms ; tyrosine kinase 3 similaire à la FMS ; tyrosine kinase 3 liée à la fms ; tyrosine kinase du récepteur des facteurs de croissance type III ; Ly72 ; OTTHUMP00000214829 ; tyrosine-protéine kinase de type récepteur FLT3 ; RP11-153M24.3 ; tyrosine kinase de la cellule souche 1 ; STK1 ; protéine-kinase FLK3 ; protéine FLtyrosine ; protéine FLT3 associée à la tyrosine
Dose range
0.246 to 60 ng/mL
Sensitivity of the dosage
0.24 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human Flt-3 quantitates human Flt-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Flt-3.

Human Flt-3 quantitates human Flt-3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Flt-3.

This gene codes a tyrosine kinase of the Class III receptor that regulates the haematopoiesis. The receptor consists of an extracellular domain consisting of five domains similar to l-immunoglobulin, a transmembrane region and a cytoplasmic kinase domain divided into two parts by a kinase-insert domain. The receptor is activated by binding of tyrosine kinase 3 ligand associated with extracellular fms, which induces the homodomer formation in the plasma membrane leading to the receptor selfphosphorylation. The kinase of the phosphoryl activated receptors subsequently activates several cytoplasmic effecting molecules in the pathways involved in the apoptosis, proliferation and differentiation of haematopoietic cells in the bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukaemia and acute lymphoblastic leukaemia.

Sensitivity

Sensitivity of the assay: 0.24 ng/mL.

Measurement range

Dose range: 0.246 to 60 ng/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: FLT3 (CD135).

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17174949
Specifications
Accession numberB230315G04; CD135; CD135 antigen; foetal liver kinase 2; foetal liver kinase-2; cytokine FL receptor; Flk2; Flk-2; FLT3; Flt-3; tyrosine kinase 3 associated with fms; tyrosine kinase 3 similar to FMS; tyrosine kinase 3 related to fms; tyrosine kinase of the receptor of fms-related factors
Dose range0.246 to 60 ng/mL
Sensitivity of the dosage0.24 ng/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P36888
Gene symbol(s)FLT3
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetFLT3 (CD135)
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; plasma, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH197RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.